Medication adjustment of afatinib and combination therapy with sitagliptin for alleviating afatinib-induced diarrhea in rats
In conclusion, sitagliptin exhibits promising potential as a therapeutic option for managing afatinib-induced diarrhea. Taken together, our study provides valuable insights into alleviating afatinib-induced diarrhea through both afatinib medication adjustment and sitagliptin combination therapy.PMID:37567055 | DOI:10.1016/j.neo.2023.100922
Source: Neoplasia - Category: Cancer & Oncology Authors: Li Zhang Anna Hu Yan Wang Yuxin Yang Yalan Liu Lian Xu Lei Wang Zeneng Cheng Source Type: research
More News: Cancer | Cancer & Oncology | Epithelial Cancer | Gastroenterology | Januvia | Lung Cancer | Non-Small Cell Lung Cancer | Study